Hormone receptor positive advanced breast cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Histologically confirmed advanced breast cancer, including inoperable locally advanced breast cancer, newly diagnosed stage IV (according to AJCC 8th Edition) or recurrent / metastatic breast cancer; 2. Estrogen receptor (ER) and / or progesterone receptor (PR) were positive; 3. HER-2 (-) or (1 +) was detected by immunohistochemistry, and HER-2 (2 +) must be detected by fish and the result was negative; 4. All premenopausal patients received ovariectomy or ovarian function inhibitors; 5. Have at least one measurable lesion; 6. The patient voluntarily joined the project and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women; 2. Combined chemotherapy; 3. According to the judgment of the researchers, there are serious hazards to the safety of patients or the accompanying diseases that affect the patients to complete the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression-free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| overall survival; | — |
Countries
China
Contacts
Mianchi People's Hospital